REBECCA SPIVEY: Open Payments
NPI 1790321552 · HIXSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $125 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $193 |
| Otsuka America Pharmaceutical, Inc. | 6 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $126 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $14 |
Products named: REXULTI, UZEDY, CAPLYTA, SPRAVATO, AUSTEDO XR, COBENFY, TRINTELLIX, FANAPT.
Industry payments across TN — which companies pay providers there.
